Evidence-Based Support for Sleep Bruxism Treatment Other Than Oral Appliances Remains Insufficient

Aranha, Ricardo Luiz de Barreto; Abreu, Mauro Henrique Nogueira Guimarães de; Serra-Negra, Júnia Maria; Martins, Renata Castro

doi:10.1016/j.jebdp.2018.03.003

Cited by 7 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results revealed a significant improvement in patients' pain levels during follow-up, with only 8% experiencing an adverse reaction. In contrast to the authors discussed previously, Manfredini et al, (2015), Aranha et al, (2018), Canales et al, (2018) Unlike the published SR, the results of Céron et al ( 2023), when using the AMSTAR 2 tool to evaluate their methodological quality, indicated that there is no conclusive and clear evidence for the use of TxBA for the management of BS.…”

Section: Discussionmentioning

confidence: 79%

Efficacy of botulinum toxin type A in bruxism: a scoping review

Júnior,

Pereira,

Dias

et al. 2023

CLIUM

View full text Add to dashboard Cite

This study aims to carry out a scoping review on the scientific production of the effectiveness of TxBA for bruxism. Eligibility criteria were defined as studies on the effectiveness of TxBA for bruxism, published in scientific publications until July 2023.This research revealed a variety of methodological approaches and data interpretation on the effectiveness of bruxism management using TxBA. Studies, including randomised clinical trials and case reports, have shown consistent results, highlighting the effectiveness of TxBA in reducing symptoms and signs of bruxism, although with variations in doses and assessment methods. Systematic reviews and overviews also confirmed the benefits, pointing to a reduction in the frequency of bruxism and muscle relaxation. However, the general assessment indicated divergences in the evidence, highlighting the need for research with better methodological rigour to establish definitive conclusions about the use of TxBA in the management of bruxism. Therefore, while the evidence points to the potential effectiveness of TxBA, uncertainty persists due to methodological variation and the lack of studies with methodological characteristics that converge with each other.

show abstract

Section: Discussionmentioning

confidence: 79%

Efficacy of botulinum toxin type A in bruxism: a scoping review

Júnior,

Pereira,

Dias

et al. 2023

CLIUM

View full text Add to dashboard Cite

show abstract

“…A recent systematic review found efficacy with all types of oral appliances, specifically mandibular advancement devices in reducing SRB (107,108). The same authors also report moderate efficacy for botulinum toxin, clonazepam, clonidine, and electrical stimuli of the masseter muscles.…”

Section: Managementmentioning

confidence: 95%

Sleep related bruxism—comprehensive review of the literature based on a rare case presentation

Thomas¹,

Patel²,

Kumar³

et al. 2024

Front Oral Maxillofac Med

View full text Add to dashboard Cite

Objective: To perform a comprehensive review of the literature on sleep related bruxism (SRB) based on the presentation of a rare case.Background: SRB is currently classified by the American Academy of Sleep Medicine (AASM) as a sleep related movement disorder. Multiple etiological factors have been reported as contributing to the development of this disorder. Genetics may be one of them. We describe the literature on this entity as related to an unusual case of the disorder being transmitted over four generations in a family.Methods: A comprehensive history and clinical features in the patient, as well as the possible genetic factors were delineated. A thorough literature search on the topic was performed based on PubMed, Web of Science, Embase, Scopus, Medline.Discussion: The SRB in this family has been transmitted through the four generations; however, one of the twins in the fourth generation is exhibiting symptoms. The sensory, autonomic, and motor mechanisms involved in the pathophysiology and presentation of SRB is currently poorly understood. We attempt to elucidate the known mechanisms and explore the possible neurophysiological pathways as related to this entity.Conclusions: SRB can have a strong genetic predisposition. The reason for the entity to skip one of the twins in the fourth generation is unknown.

show abstract

“…The collected articles were reviewed thoroughly for obtaining the relevant information. [10][11][12][13][14][15][16][17][18]…”

Section: Methodsmentioning

confidence: 99%

“…The treatment of sleep bruxism usually begins with counselling of the patient with reference to the sleep hygiene. It includes to instruct the bruxer to prevent smoking and drinking of coffee or alcohol at night, to limit the physical or mental activity before getting to bed, and to make sure good bedroom conditions like quiet and dark [29] (d) Biofeedback Biofeedback works on the principle that "bruxers…”

Section: Managementmentioning

confidence: 99%

Diagnosis and Management of Sleep Bruxism

Kumar¹,

Nair²,

Faizal³

et al. 2022

JPID

View full text Add to dashboard Cite

Sleep bruxism is a common phenomenon caused due to masticatory muscle activity during sleep .Proper methods for screening and diagnosing patients with Sleep Bruxism are crucial for the success of dental treatment. Literature reviews and clinical experiences indicate a lack of patient awareness and underreporting of sleep bruxism. Clinicians should look for clinical signs and symptoms of Sleep bruxism in the patient and deliver minimally invasive treatment modalities.

show abstract

Evidence-Based Support for Sleep Bruxism Treatment Other Than Oral Appliances Remains Insufficient

Cited by 7 publications

References 12 publications

Efficacy of botulinum toxin type A in bruxism: a scoping review

Efficacy of botulinum toxin type A in bruxism: a scoping review

Sleep related bruxism—comprehensive review of the literature based on a rare case presentation

Diagnosis and Management of Sleep Bruxism

Contact Info

Product

Resources

About